Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders Review
| Authors: | Ulaner, G. A.; Landgren, C. O. |
| Review Title: | Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders |
| Abstract: | Fluorine-18 (18F)-fluorodeoxyglucose (FDG) positron emission tomography (PET) allows evaluation of elevated glucose metabolism in malignancies. There has been increasing interest in FDG PET/CT for plasma cell disorders since the International Myeloma Working Group outlined multiple applications of this imaging modality, including distinguishing smoldering myeloma from active multiple myeloma, confirmation of solitary plasmacytoma, and multiple indications in patients with known multiple myeloma, including determining extent of initial disease, monitoring therapy response, and detection of residual disease following therapy. The field of molecular imaging is now shifting focus from evaluation of metabolism to targeted evaluation of specific tumor markers. Targeted PET imaging targeted of CXCR4 and CD38 has advanced into translational clinical trials, bringing us closer to powerful imaging options for myeloma. In this review we discuss the current applications of FDG PET/CT in plasma cell disorders, as well as advances in targeted PET imaging. © 2020 |
| Keywords: | treatment response; review; cancer diagnosis; multiple myeloma; plasmacytoma; molecular imaging; plasma cell; minimal residual disease; fluorodeoxyglucose f 18; positron emission tomography (pet); chemokine receptor cxcr4; immunopet; smoldering multiple myeloma; disease burden; human; priority journal; b cell maturation antigen; positron emission tomography-computed tomography; 18f-fluorodeoxyglucose (fdg) |
| Journal Title: | Best Practice and Research: Clinical Haematology |
| Volume: | 33 |
| Issue: | 1 |
| ISSN: | 1521-6926 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-03-01 |
| Start Page: | 101148 |
| Language: | English |
| DOI: | 10.1016/j.beha.2020.101148 |
| PUBMED: | 32139013 |
| PROVIDER: | scopus |
| PMCID: | PMC7410322 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 April 2020 -- Source: Scopus |
Altmetric
Citation Impact
Related MSK Work